CH568302A5 - - Google Patents

Info

Publication number
CH568302A5
CH568302A5 CH1027675A CH1027675A CH568302A5 CH 568302 A5 CH568302 A5 CH 568302A5 CH 1027675 A CH1027675 A CH 1027675A CH 1027675 A CH1027675 A CH 1027675A CH 568302 A5 CH568302 A5 CH 568302A5
Authority
CH
Switzerland
Application number
CH1027675A
Original Assignee
Wellcome Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wellcome Found filed Critical Wellcome Found
Publication of CH568302A5 publication Critical patent/CH568302A5/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/32One oxygen, sulfur or nitrogen atom
    • C07D239/42One nitrogen atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00Carboxylic acid nitriles
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C317/00Sulfones; Sulfoxides
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/61Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups
    • C07C45/67Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton
    • C07C45/68Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/48Two nitrogen atoms
    • C07D239/49Two nitrogen atoms with an aralkyl radical, or substituted aralkyl radical, attached in position 5, e.g. trimethoprim
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
CH1027675A 1970-10-22 1971-10-21 CH568302A5 (sv)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB963871*[A GB1375162A (sv) 1970-10-22 1970-10-22
GB963871 1971-04-16
GB4749171 1971-10-12

Publications (1)

Publication Number Publication Date
CH568302A5 true CH568302A5 (sv) 1975-10-31

Family

ID=27255400

Family Applications (3)

Application Number Title Priority Date Filing Date
CH1532171A CH568301A5 (sv) 1970-10-22 1971-10-21
CH1027775A CH582681A5 (sv) 1970-10-22 1971-10-21
CH1027675A CH568302A5 (sv) 1970-10-22 1971-10-21

Family Applications Before (2)

Application Number Title Priority Date Filing Date
CH1532171A CH568301A5 (sv) 1970-10-22 1971-10-21
CH1027775A CH582681A5 (sv) 1970-10-22 1971-10-21

Country Status (20)

Country Link
JP (2) JPS5536662B1 (sv)
AR (3) AR192588A1 (sv)
AT (1) AT319948B (sv)
BE (1) BE774281A (sv)
BG (4) BG20797A3 (sv)
CA (1) CA967158A (sv)
CH (3) CH568301A5 (sv)
DD (1) DD100877A5 (sv)
DK (1) DK132174C (sv)
ES (1) ES396219A1 (sv)
FI (1) FI56175C (sv)
FR (1) FR2111769B1 (sv)
GB (1) GB1375162A (sv)
IE (1) IE37452B1 (sv)
IL (2) IL45422A (sv)
LU (1) LU64129A1 (sv)
MC (1) MC894A1 (sv)
NL (1) NL175178C (sv)
SE (2) SE384505B (sv)
ZM (1) ZM14971A1 (sv)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE792096A (fr) * 1971-12-01 1973-05-30 Hoffmann La Roche Nouvelles benzylpyrimidines
FR2397407A2 (fr) * 1977-07-11 1979-02-09 Dick Pierre Derives de 2,4-diamino pyrimidines et leur mise en solution en association avec des sulfamides
NO791699L (no) * 1978-05-24 1979-11-27 Wellcome Found Benzylpyrimidinforbindelser og fremgangsmaate til deres fremstilling
JPS61156909A (ja) * 1984-12-27 1986-07-16 Matsushita Electric Ind Co Ltd カレント・ミラ−回路
JPS62145907A (ja) * 1985-12-20 1987-06-30 Hitachi Ltd トランジスタ回路
TWI414525B (zh) 2004-03-26 2013-11-11 Dainippon Sumitomo Pharma Co 9-取代-8-氧基腺嘌呤化合物
US8138172B2 (en) 2006-07-05 2012-03-20 Astrazeneca Ab 8-oxoadenine derivatives acting as modulators of TLR7
TW200831105A (en) 2006-12-14 2008-08-01 Astrazeneca Ab Novel compounds
WO2008114006A1 (en) 2007-03-19 2008-09-25 Astrazeneca Ab 9-substituted-8-oxo-adenine compounds as toll-like receptor (tlr7) modulators
PT2132209E (pt) 2007-03-19 2014-04-15 Astrazeneca Ab Compostos de 8-oxo-adenina substituídos na posição 9, como moduladores do recetor de tipo ¿toll¿ (tlr7)
EP2138497A4 (en) 2007-03-20 2012-01-04 Dainippon Sumitomo Pharma Co NEW ADENINE CONNECTION
PE20091236A1 (es) * 2007-11-22 2009-09-16 Astrazeneca Ab Derivados de pirimidina como immunomoduladores de tlr7
PE20091156A1 (es) 2007-12-17 2009-09-03 Astrazeneca Ab Sales de (3-{[[3-(6-amino-2-butoxi-8-oxo-7,8-dihidro-9h-purin-9-il)propil](3-morfolin-4-ilpropil)amino]metil}fenil)acetato de metilo
CN102482233A (zh) 2009-05-21 2012-05-30 阿斯利康(瑞典)有限公司 新颖的嘧啶衍生物和它们在治疗癌症和其它疾病中的用途
GB0908772D0 (en) 2009-05-21 2009-07-01 Astrazeneca Ab New salts 756
ES2575688T3 (es) 2010-12-16 2016-06-30 Sumitomo Dainippon Pharma Co., Ltd. Derivado de imidazo[4,5-c]quinolin-1-ilo útil en terapia
US8895570B2 (en) 2010-12-17 2014-11-25 Astrazeneca Ab Purine derivatives
CN104302628B (zh) 2012-05-18 2017-06-23 大日本住友制药株式会社 羧酸化合物

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE710100A (sv) * 1967-02-02 1968-07-30
JPS511716A (ja) * 1974-06-25 1976-01-08 Toray Industries Horiesuterumaruchifuiramentono seiho

Also Published As

Publication number Publication date
BE774281A (fr) 1972-04-21
AT319948B (de) 1975-01-10
CA967158A (en) 1975-05-06
JPS5536662B1 (sv) 1980-09-22
SE384505B (sv) 1976-05-10
NL175178B (nl) 1984-05-01
MC894A1 (fr) 1972-06-22
DK132174B (da) 1975-11-03
BG21406A3 (bg) 1976-05-20
BG20797A3 (bg) 1975-12-20
AR192588A1 (es) 1973-02-28
AR192802A1 (es) 1973-03-14
IL37984A0 (en) 1971-12-29
FR2111769B1 (sv) 1974-10-18
ES396219A1 (es) 1975-09-16
ZM14971A1 (en) 1972-07-21
BG20364A3 (bg) 1975-11-05
FI56175C (fi) 1979-12-10
NL7114494A (sv) 1972-04-25
LU64129A1 (sv) 1972-06-28
CH568301A5 (sv) 1975-10-31
CH582681A5 (sv) 1976-12-15
JPS53135991A (en) 1978-11-28
NL175178C (nl) 1984-10-01
SE409705B (sv) 1979-09-03
IL37984A (en) 1976-03-31
FR2111769A1 (sv) 1972-06-09
IL45422A (en) 1976-03-31
DD100877A5 (sv) 1973-10-12
DK132174C (da) 1976-03-29
IE37452B1 (en) 1977-08-03
GB1375162A (sv) 1974-11-27
FI56175B (fi) 1979-08-31
BG20365A3 (bg) 1975-11-05
AR192803A1 (es) 1973-03-14
IE37452L (en) 1972-04-22

Similar Documents

Publication Publication Date Title
AR204384A1 (sv)
FR2111769B1 (sv)
ATA96471A (sv)
AU1146470A (sv)
AU2044470A (sv)
AU2017870A (sv)
AU1336970A (sv)
AR195465A1 (sv)
AU1918570A (sv)
AU1189670A (sv)
AU1277070A (sv)
AU1879170A (sv)
AU1881070A (sv)
AU1974970A (sv)
AU2112570A (sv)
AU1083170A (sv)
AU1064870A (sv)
AU1004470A (sv)
AU1343870A (sv)
AU1247570A (sv)
AU1328670A (sv)
AU1969370A (sv)
ATA672271A (sv)
AU2144270A (sv)
AU1943370A (sv)

Legal Events

Date Code Title Description
PL Patent ceased